Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature

Poorly differentiated cancers are a diagnostic and therapeutic challenge in oncology. New therapies are needed for patients with poorly differentiated thyroid carcinoma (PDTC) or anaplastic thyroid cancer, as these patients often present with advanced disease and effective systemic treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Lote, Hazel, Bhosle, Jaishree, Thway, Khin, Newbold, Kate, O'Brien, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: June, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107819/
https://www.ncbi.nlm.nih.gov/pubmed/25076890
http://dx.doi.org/10.1159/000364856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107819/
https://www.ncbi.nlm.nih.gov/pubmed/25076890
http://dx.doi.org/10.1159/000364856

Ejemplares similares